Some coronavirus patients 'cured' in South Korea tested positive again

South Korea coronavirus.
(Image credit: JUNG YEON-JE/AFP via Getty Images)

The notion of coronavirus immunity is still in question after an announcement from South Korea's CDC.

In a Monday briefing, South Korea's Centers for Disease Control and Prevention announced 51 people "cured" after contracting COVID-19 had tested positive for the disease after being released from quarantine. CDC Director Jeong Eun-kyeong leaned toward deeming these cases a "reactivation" of the virus, but will study it further.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

But this latest announcement calls the herd immunity strategy into further question. Patients are deemed recovered when they test negative for the disease twice in 24 hours. Yet in at least 51 cases, people who had apparently recovered had tested positive again shortly after they left quarantine. "While we are putting more weight on reactivation as the possible cause, we are conducting a comprehensive study on this," Jeong said. Those patients may not have even been cured at all, seeing as "there have been many cases when a patient during treatment will test negative one day and positive another," he said.

Explore More

Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.